Lonza Group AG/ US54338V1017 /
2024-05-15 7:50:01 PM | Chg. +2.5450 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
58.8400USD | +4.52% | 17,181 Turnover: 832,149.3627 |
-Bid Size: - | -Ask Size: - | 59.0180 | 58.0800 |
GlobeNewswire
04-04
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire
2023-10-16
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire
2023-09-07
Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire
2021-11-02
Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strate...
GlobeNewswire
2021-09-08
Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment o...
GlobeNewswire
2021-04-14
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
GlobeNewswire
2021-01-12
Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the...
GlobeNewswire
2021-01-08
Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
GlobeNewswire
2020-12-23
Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
GlobeNewswire
2020-11-10
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal V...
GlobeNewswire
2020-09-04
Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
GlobeNewswire
2020-02-06
Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic...
GlobeNewswire
2020-01-02
Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
GlobeNewswire
2019-12-04
Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined w...
GlobeNewswire
2019-11-21
Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorder...
GlobeNewswire
2019-11-14
Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test...
GlobeNewswire
2019-10-29
Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Imm...